nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—lung cancer	0.272	0.585	CbGaD
Methimazole—CYP2E1—lung cancer	0.193	0.415	CbGaD
Methimazole—CYP2C19—Gefitinib—lung cancer	0.0251	0.0708	CbGbCtD
Methimazole—CYP2C19—Teniposide—lung cancer	0.0243	0.0686	CbGbCtD
Methimazole—CYP2B6—Irinotecan—lung cancer	0.0211	0.0595	CbGbCtD
Methimazole—CYP2C9—Gefitinib—lung cancer	0.0209	0.0589	CbGbCtD
Methimazole—CYP2C9—Teniposide—lung cancer	0.0202	0.0571	CbGbCtD
Methimazole—CYP2D6—Gefitinib—lung cancer	0.0191	0.0538	CbGbCtD
Methimazole—CYP2B6—Cisplatin—lung cancer	0.0172	0.0485	CbGbCtD
Methimazole—CYP2E1—Etoposide—lung cancer	0.0171	0.0483	CbGbCtD
Methimazole—CYP2D6—Vinorelbine—lung cancer	0.0147	0.0415	CbGbCtD
Methimazole—CYP1A2—Erlotinib—lung cancer	0.0137	0.0386	CbGbCtD
Methimazole—CYP3A4—Topotecan—lung cancer	0.0133	0.0374	CbGbCtD
Methimazole—CYP3A4—Gefitinib—lung cancer	0.0121	0.0342	CbGbCtD
Methimazole—CYP3A4—Teniposide—lung cancer	0.0118	0.0332	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—lung cancer	0.0115	0.0325	CbGbCtD
Methimazole—CYP2C9—Paclitaxel—lung cancer	0.0113	0.0319	CbGbCtD
Methimazole—CYP2D6—Erlotinib—lung cancer	0.0113	0.0318	CbGbCtD
Methimazole—CYP1A2—Etoposide—lung cancer	0.0099	0.0279	CbGbCtD
Methimazole—CYP3A4—Vinorelbine—lung cancer	0.00934	0.0264	CbGbCtD
Methimazole—CYP2C9—Cisplatin—lung cancer	0.00908	0.0256	CbGbCtD
Methimazole—CYP2D6—Vinblastine—lung cancer	0.00905	0.0256	CbGbCtD
Methimazole—CYP3A4—Crizotinib—lung cancer	0.00743	0.021	CbGbCtD
Methimazole—CYP3A4—Erlotinib—lung cancer	0.00717	0.0202	CbGbCtD
Methimazole—CYP3A4—Paclitaxel—lung cancer	0.00656	0.0185	CbGbCtD
Methimazole—CYP3A4—Irinotecan—lung cancer	0.00647	0.0183	CbGbCtD
Methimazole—CYP3A4—Vinblastine—lung cancer	0.00576	0.0162	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—lung cancer	0.00556	0.0157	CbGbCtD
Methimazole—CYP3A4—Etoposide—lung cancer	0.00519	0.0146	CbGbCtD
Methimazole—CYP3A4—Docetaxel—lung cancer	0.00474	0.0134	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—lung cancer	0.00354	0.00998	CbGbCtD
Methimazole—Thrombocytopenia—Gefitinib—lung cancer	0.000555	0.00638	CcSEcCtD
Methimazole—Dyspepsia—Crizotinib—lung cancer	0.000549	0.00632	CcSEcCtD
Methimazole—Neuropathy peripheral—Vinblastine—lung cancer	0.000542	0.00623	CcSEcCtD
Methimazole—Neuropathy peripheral—Topotecan—lung cancer	0.000526	0.00605	CcSEcCtD
Methimazole—Neuropathy peripheral—Erlotinib—lung cancer	0.000521	0.00599	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.00052	0.00598	CcSEcCtD
Methimazole—Agranulocytosis—Vinblastine—lung cancer	0.000516	0.00593	CcSEcCtD
Methimazole—Leukopenia—Teniposide—lung cancer	0.000507	0.00583	CcSEcCtD
Methimazole—Dyspepsia—Pemetrexed—lung cancer	0.000502	0.00577	CcSEcCtD
Methimazole—Body temperature increased—Crizotinib—lung cancer	0.000493	0.00567	CcSEcCtD
Methimazole—Hepatitis—Erlotinib—lung cancer	0.000477	0.00548	CcSEcCtD
Methimazole—Oedema—Teniposide—lung cancer	0.000462	0.00531	CcSEcCtD
Methimazole—Urticaria—Pemetrexed—lung cancer	0.000453	0.00521	CcSEcCtD
Methimazole—Thrombocytopenia—Teniposide—lung cancer	0.000452	0.0052	CcSEcCtD
Methimazole—Body temperature increased—Pemetrexed—lung cancer	0.000451	0.00518	CcSEcCtD
Methimazole—Urticaria—Gefitinib—lung cancer	0.00045	0.00518	CcSEcCtD
Methimazole—Neuropathy peripheral—Vinorelbine—lung cancer	0.00045	0.00518	CcSEcCtD
Methimazole—Body temperature increased—Gefitinib—lung cancer	0.000448	0.00515	CcSEcCtD
Methimazole—Alopecia—Vinblastine—lung cancer	0.000438	0.00504	CcSEcCtD
Methimazole—Agranulocytosis—Vinorelbine—lung cancer	0.000429	0.00493	CcSEcCtD
Methimazole—Alopecia—Topotecan—lung cancer	0.000426	0.0049	CcSEcCtD
Methimazole—Alopecia—Erlotinib—lung cancer	0.000421	0.00485	CcSEcCtD
Methimazole—Pruritus—Pemetrexed—lung cancer	0.000404	0.00464	CcSEcCtD
Methimazole—Pruritus—Gefitinib—lung cancer	0.000401	0.00461	CcSEcCtD
Methimazole—Vomiting—Crizotinib—lung cancer	0.000397	0.00456	CcSEcCtD
Methimazole—Rash—Crizotinib—lung cancer	0.000394	0.00452	CcSEcCtD
Methimazole—Dermatitis—Crizotinib—lung cancer	0.000393	0.00452	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—lung cancer	0.000391	0.0045	CcSEcCtD
Methimazole—Vertigo—Vinblastine—lung cancer	0.000388	0.00446	CcSEcCtD
Methimazole—Leukopenia—Vinblastine—lung cancer	0.000387	0.00445	CcSEcCtD
Methimazole—Leukopenia—Topotecan—lung cancer	0.000376	0.00432	CcSEcCtD
Methimazole—Nausea—Crizotinib—lung cancer	0.000371	0.00426	CcSEcCtD
Methimazole—Jaundice—Irinotecan—lung cancer	0.000369	0.00425	CcSEcCtD
Methimazole—Urticaria—Teniposide—lung cancer	0.000367	0.00422	CcSEcCtD
Methimazole—Body temperature increased—Teniposide—lung cancer	0.000365	0.0042	CcSEcCtD
Methimazole—Alopecia—Vinorelbine—lung cancer	0.000364	0.00419	CcSEcCtD
Methimazole—Vomiting—Pemetrexed—lung cancer	0.000363	0.00417	CcSEcCtD
Methimazole—Neuropathy peripheral—Gemcitabine—lung cancer	0.000362	0.00416	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—lung cancer	0.000361	0.00415	CcSEcCtD
Methimazole—Vomiting—Gefitinib—lung cancer	0.00036	0.00414	CcSEcCtD
Methimazole—Rash—Pemetrexed—lung cancer	0.00036	0.00414	CcSEcCtD
Methimazole—Dermatitis—Pemetrexed—lung cancer	0.000359	0.00413	CcSEcCtD
Methimazole—Rash—Gefitinib—lung cancer	0.000357	0.00411	CcSEcCtD
Methimazole—Myalgia—Topotecan—lung cancer	0.000357	0.00411	CcSEcCtD
Methimazole—Arthralgia—Topotecan—lung cancer	0.000357	0.00411	CcSEcCtD
Methimazole—Dermatitis—Gefitinib—lung cancer	0.000357	0.0041	CcSEcCtD
Methimazole—Arthralgia—Erlotinib—lung cancer	0.000353	0.00406	CcSEcCtD
Methimazole—Myalgia—Erlotinib—lung cancer	0.000353	0.00406	CcSEcCtD
Methimazole—Thrombocytopenia—Vinblastine—lung cancer	0.000345	0.00397	CcSEcCtD
Methimazole—Agranulocytosis—Gemcitabine—lung cancer	0.000344	0.00396	CcSEcCtD
Methimazole—Oedema—Erlotinib—lung cancer	0.000339	0.0039	CcSEcCtD
Methimazole—Nausea—Pemetrexed—lung cancer	0.000339	0.0039	CcSEcCtD
Methimazole—Neuropathy peripheral—Cisplatin—lung cancer	0.000337	0.00388	CcSEcCtD
Methimazole—Nausea—Gefitinib—lung cancer	0.000337	0.00387	CcSEcCtD
Methimazole—Thrombocytopenia—Topotecan—lung cancer	0.000335	0.00386	CcSEcCtD
Methimazole—Thrombocytopenia—Erlotinib—lung cancer	0.000332	0.00381	CcSEcCtD
Methimazole—Pruritus—Teniposide—lung cancer	0.000327	0.00376	CcSEcCtD
Methimazole—Vertigo—Vinorelbine—lung cancer	0.000323	0.00371	CcSEcCtD
Methimazole—Leukopenia—Vinorelbine—lung cancer	0.000321	0.00369	CcSEcCtD
Methimazole—Aplastic anaemia—Methotrexate—lung cancer	0.000317	0.00364	CcSEcCtD
Methimazole—Paraesthesia—Vinblastine—lung cancer	0.000317	0.00364	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Topotecan—lung cancer	0.000312	0.00359	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—lung cancer	0.000309	0.00355	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000309	0.00355	CcSEcCtD
Methimazole—Paraesthesia—Topotecan—lung cancer	0.000308	0.00354	CcSEcCtD
Methimazole—Jaundice—Etoposide—lung cancer	0.000307	0.00353	CcSEcCtD
Methimazole—Myalgia—Vinorelbine—lung cancer	0.000306	0.00351	CcSEcCtD
Methimazole—Arthralgia—Vinorelbine—lung cancer	0.000306	0.00351	CcSEcCtD
Methimazole—Neuropathy peripheral—Paclitaxel—lung cancer	0.000303	0.00348	CcSEcCtD
Methimazole—Dyspepsia—Topotecan—lung cancer	0.000301	0.00347	CcSEcCtD
Methimazole—Alopecia—Irinotecan—lung cancer	0.000301	0.00346	CcSEcCtD
Methimazole—Dyspepsia—Erlotinib—lung cancer	0.000298	0.00343	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—lung cancer	0.000294	0.00338	CcSEcCtD
Methimazole—Vomiting—Teniposide—lung cancer	0.000294	0.00338	CcSEcCtD
Methimazole—Alopecia—Gemcitabine—lung cancer	0.000293	0.00337	CcSEcCtD
Methimazole—Rash—Teniposide—lung cancer	0.000291	0.00335	CcSEcCtD
Methimazole—Dermatitis—Teniposide—lung cancer	0.000291	0.00335	CcSEcCtD
Methimazole—Headache—Teniposide—lung cancer	0.000289	0.00333	CcSEcCtD
Methimazole—Lymphadenopathy—Methotrexate—lung cancer	0.000287	0.0033	CcSEcCtD
Methimazole—Thrombocytopenia—Vinorelbine—lung cancer	0.000287	0.0033	CcSEcCtD
Methimazole—Nausea—Teniposide—lung cancer	0.000274	0.00316	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—lung cancer	0.000274	0.00315	CcSEcCtD
Methimazole—Alopecia—Cisplatin—lung cancer	0.000273	0.00314	CcSEcCtD
Methimazole—Urticaria—Topotecan—lung cancer	0.000272	0.00313	CcSEcCtD
Methimazole—Body temperature increased—Topotecan—lung cancer	0.000271	0.00311	CcSEcCtD
Methimazole—Body temperature increased—Erlotinib—lung cancer	0.000268	0.00308	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000267	0.00307	CcSEcCtD
Methimazole—Vertigo—Irinotecan—lung cancer	0.000266	0.00306	CcSEcCtD
Methimazole—Leukopenia—Irinotecan—lung cancer	0.000265	0.00305	CcSEcCtD
Methimazole—Paraesthesia—Vinorelbine—lung cancer	0.000263	0.00302	CcSEcCtD
Methimazole—Leukopenia—Gemcitabine—lung cancer	0.000258	0.00297	CcSEcCtD
Methimazole—Neuropathy peripheral—Docetaxel—lung cancer	0.000257	0.00295	CcSEcCtD
Methimazole—Jaundice—Docetaxel—lung cancer	0.000255	0.00293	CcSEcCtD
Methimazole—Alopecia—Etoposide—lung cancer	0.00025	0.00287	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—lung cancer	0.000249	0.00286	CcSEcCtD
Methimazole—Myalgia—Gemcitabine—lung cancer	0.000246	0.00282	CcSEcCtD
Methimazole—Arthralgia—Gemcitabine—lung cancer	0.000246	0.00282	CcSEcCtD
Methimazole—Alopecia—Paclitaxel—lung cancer	0.000245	0.00282	CcSEcCtD
Methimazole—Agranulocytosis—Docetaxel—lung cancer	0.000244	0.00281	CcSEcCtD
Methimazole—Pruritus—Topotecan—lung cancer	0.000242	0.00279	CcSEcCtD
Methimazole—Oedema—Irinotecan—lung cancer	0.000242	0.00278	CcSEcCtD
Methimazole—Leukopenia—Cisplatin—lung cancer	0.000241	0.00277	CcSEcCtD
Methimazole—Pruritus—Erlotinib—lung cancer	0.00024	0.00276	CcSEcCtD
Methimazole—Thrombocytopenia—Irinotecan—lung cancer	0.000237	0.00272	CcSEcCtD
Methimazole—Oedema—Gemcitabine—lung cancer	0.000235	0.00271	CcSEcCtD
Methimazole—Hepatitis—Docetaxel—lung cancer	0.000235	0.0027	CcSEcCtD
Methimazole—Urticaria—Vinorelbine—lung cancer	0.000233	0.00268	CcSEcCtD
Methimazole—Body temperature increased—Vinorelbine—lung cancer	0.000232	0.00266	CcSEcCtD
Methimazole—Thrombocytopenia—Gemcitabine—lung cancer	0.00023	0.00265	CcSEcCtD
Methimazole—Myalgia—Cisplatin—lung cancer	0.000229	0.00263	CcSEcCtD
Methimazole—Vomiting—Vinblastine—lung cancer	0.000224	0.00258	CcSEcCtD
Methimazole—Vertigo—Etoposide—lung cancer	0.000221	0.00254	CcSEcCtD
Methimazole—Headache—Vinblastine—lung cancer	0.000221	0.00254	CcSEcCtD
Methimazole—Leukopenia—Etoposide—lung cancer	0.00022	0.00253	CcSEcCtD
Methimazole—Oedema—Cisplatin—lung cancer	0.000219	0.00252	CcSEcCtD
Methimazole—Vomiting—Topotecan—lung cancer	0.000218	0.0025	CcSEcCtD
Methimazole—Paraesthesia—Irinotecan—lung cancer	0.000217	0.00249	CcSEcCtD
Methimazole—Vertigo—Paclitaxel—lung cancer	0.000217	0.00249	CcSEcCtD
Methimazole—Leukopenia—Paclitaxel—lung cancer	0.000216	0.00248	CcSEcCtD
Methimazole—Rash—Topotecan—lung cancer	0.000216	0.00248	CcSEcCtD
Methimazole—Dermatitis—Topotecan—lung cancer	0.000216	0.00248	CcSEcCtD
Methimazole—Vomiting—Erlotinib—lung cancer	0.000215	0.00248	CcSEcCtD
Methimazole—Somnolence—Irinotecan—lung cancer	0.000215	0.00247	CcSEcCtD
Methimazole—Thrombocytopenia—Cisplatin—lung cancer	0.000215	0.00247	CcSEcCtD
Methimazole—Headache—Topotecan—lung cancer	0.000215	0.00247	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000214	0.00247	CcSEcCtD
Methimazole—Rash—Erlotinib—lung cancer	0.000214	0.00246	CcSEcCtD
Methimazole—Dermatitis—Erlotinib—lung cancer	0.000213	0.00245	CcSEcCtD
Methimazole—Dyspepsia—Irinotecan—lung cancer	0.000213	0.00245	CcSEcCtD
Methimazole—Headache—Erlotinib—lung cancer	0.000212	0.00244	CcSEcCtD
Methimazole—Paraesthesia—Gemcitabine—lung cancer	0.000211	0.00243	CcSEcCtD
Methimazole—Nausea—Vinblastine—lung cancer	0.000209	0.00241	CcSEcCtD
Methimazole—Somnolence—Gemcitabine—lung cancer	0.000209	0.00241	CcSEcCtD
Methimazole—Alopecia—Docetaxel—lung cancer	0.000208	0.00239	CcSEcCtD
Methimazole—Pruritus—Vinorelbine—lung cancer	0.000207	0.00238	CcSEcCtD
Methimazole—Arthralgia—Paclitaxel—lung cancer	0.000206	0.00236	CcSEcCtD
Methimazole—Myalgia—Paclitaxel—lung cancer	0.000206	0.00236	CcSEcCtD
Methimazole—Nausea—Topotecan—lung cancer	0.000203	0.00234	CcSEcCtD
Methimazole—Nausea—Erlotinib—lung cancer	0.000201	0.00231	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Cisplatin—lung cancer	0.0002	0.0023	CcSEcCtD
Methimazole—Oedema—Paclitaxel—lung cancer	0.000197	0.00227	CcSEcCtD
Methimazole—Paraesthesia—Cisplatin—lung cancer	0.000197	0.00226	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—lung cancer	0.000197	0.00226	CcSEcCtD
Methimazole—Thrombocytopenia—Paclitaxel—lung cancer	0.000193	0.00222	CcSEcCtD
Methimazole—Body temperature increased—Irinotecan—lung cancer	0.000191	0.0022	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—lung cancer	0.000189	0.00217	CcSEcCtD
Methimazole—Vomiting—Vinorelbine—lung cancer	0.000186	0.00214	CcSEcCtD
Methimazole—Body temperature increased—Gemcitabine—lung cancer	0.000186	0.00214	CcSEcCtD
Methimazole—Rash—Vinorelbine—lung cancer	0.000185	0.00212	CcSEcCtD
Methimazole—Dermatitis—Vinorelbine—lung cancer	0.000185	0.00212	CcSEcCtD
Methimazole—Headache—Vinorelbine—lung cancer	0.000184	0.00211	CcSEcCtD
Methimazole—Leukopenia—Docetaxel—lung cancer	0.000183	0.00211	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—lung cancer	0.00018	0.00207	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00018	0.00206	CcSEcCtD
Methimazole—Somnolence—Etoposide—lung cancer	0.000179	0.00205	CcSEcCtD
Methimazole—Paraesthesia—Paclitaxel—lung cancer	0.000177	0.00203	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—lung cancer	0.000176	0.00203	CcSEcCtD
Methimazole—Somnolence—Paclitaxel—lung cancer	0.000175	0.00201	CcSEcCtD
Methimazole—Arthralgia—Docetaxel—lung cancer	0.000174	0.002	CcSEcCtD
Methimazole—Myalgia—Docetaxel—lung cancer	0.000174	0.002	CcSEcCtD
Methimazole—Nausea—Vinorelbine—lung cancer	0.000174	0.002	CcSEcCtD
Methimazole—Dyspepsia—Paclitaxel—lung cancer	0.000173	0.00199	CcSEcCtD
Methimazole—Body temperature increased—Cisplatin—lung cancer	0.000173	0.00199	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—lung cancer	0.000169	0.00195	CcSEcCtD
Methimazole—Oedema—Docetaxel—lung cancer	0.000167	0.00192	CcSEcCtD
Methimazole—Pruritus—Gemcitabine—lung cancer	0.000167	0.00191	CcSEcCtD
Methimazole—Thrombocytopenia—Docetaxel—lung cancer	0.000164	0.00188	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—lung cancer	0.000163	0.00188	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—lung cancer	0.00016	0.00184	CcSEcCtD
Methimazole—Urticaria—Etoposide—lung cancer	0.00016	0.00184	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—lung cancer	0.000159	0.00183	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—lung cancer	0.000159	0.00183	CcSEcCtD
Methimazole—Urticaria—Paclitaxel—lung cancer	0.000157	0.0018	CcSEcCtD
Methimazole—Body temperature increased—Paclitaxel—lung cancer	0.000156	0.00179	CcSEcCtD
Methimazole—Vomiting—Irinotecan—lung cancer	0.000154	0.00177	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—lung cancer	0.000153	0.00175	CcSEcCtD
Methimazole—Rash—Irinotecan—lung cancer	0.000152	0.00175	CcSEcCtD
Methimazole—Dermatitis—Irinotecan—lung cancer	0.000152	0.00175	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000152	0.00175	CcSEcCtD
Methimazole—Headache—Irinotecan—lung cancer	0.000151	0.00174	CcSEcCtD
Methimazole—Paraesthesia—Docetaxel—lung cancer	0.00015	0.00172	CcSEcCtD
Methimazole—Alopecia—Methotrexate—lung cancer	0.00015	0.00172	CcSEcCtD
Methimazole—Vomiting—Gemcitabine—lung cancer	0.00015	0.00172	CcSEcCtD
Methimazole—Somnolence—Docetaxel—lung cancer	0.000148	0.00171	CcSEcCtD
Methimazole—Rash—Gemcitabine—lung cancer	0.000148	0.00171	CcSEcCtD
Methimazole—Dermatitis—Gemcitabine—lung cancer	0.000148	0.0017	CcSEcCtD
Methimazole—Headache—Gemcitabine—lung cancer	0.000147	0.0017	CcSEcCtD
Methimazole—Dyspepsia—Docetaxel—lung cancer	0.000147	0.00169	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—lung cancer	0.000147	0.00169	CcSEcCtD
Methimazole—Nausea—Irinotecan—lung cancer	0.000144	0.00165	CcSEcCtD
Methimazole—Pruritus—Etoposide—lung cancer	0.000142	0.00163	CcSEcCtD
Methimazole—Nausea—Gemcitabine—lung cancer	0.00014	0.00161	CcSEcCtD
Methimazole—Vomiting—Cisplatin—lung cancer	0.000139	0.0016	CcSEcCtD
Methimazole—Pruritus—Paclitaxel—lung cancer	0.000139	0.0016	CcSEcCtD
Methimazole—Rash—Cisplatin—lung cancer	0.000138	0.00159	CcSEcCtD
Methimazole—Dermatitis—Cisplatin—lung cancer	0.000138	0.00159	CcSEcCtD
Methimazole—Vertigo—Methotrexate—lung cancer	0.000133	0.00152	CcSEcCtD
Methimazole—Body temperature increased—Docetaxel—lung cancer	0.000132	0.00152	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—lung cancer	0.000132	0.00152	CcSEcCtD
Methimazole—Nausea—Cisplatin—lung cancer	0.00013	0.0015	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—lung cancer	0.00013	0.00149	CcSEcCtD
Methimazole—Vomiting—Etoposide—lung cancer	0.000128	0.00147	CcSEcCtD
Methimazole—Rash—Etoposide—lung cancer	0.000127	0.00146	CcSEcCtD
Methimazole—Dermatitis—Etoposide—lung cancer	0.000127	0.00146	CcSEcCtD
Methimazole—Headache—Etoposide—lung cancer	0.000126	0.00145	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—lung cancer	0.000126	0.00144	CcSEcCtD
Methimazole—Myalgia—Methotrexate—lung cancer	0.000126	0.00144	CcSEcCtD
Methimazole—Vomiting—Paclitaxel—lung cancer	0.000125	0.00144	CcSEcCtD
Methimazole—Rash—Paclitaxel—lung cancer	0.000124	0.00143	CcSEcCtD
Methimazole—Dermatitis—Paclitaxel—lung cancer	0.000124	0.00143	CcSEcCtD
Methimazole—Headache—Paclitaxel—lung cancer	0.000123	0.00142	CcSEcCtD
Methimazole—Nausea—Etoposide—lung cancer	0.000119	0.00137	CcSEcCtD
Methimazole—Pruritus—Docetaxel—lung cancer	0.000118	0.00136	CcSEcCtD
Methimazole—Thrombocytopenia—Methotrexate—lung cancer	0.000118	0.00136	CcSEcCtD
Methimazole—Nausea—Paclitaxel—lung cancer	0.000117	0.00135	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—lung cancer	0.000115	0.00132	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—lung cancer	0.000114	0.00131	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00011	0.00126	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—lung cancer	0.000109	0.00125	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—lung cancer	0.000109	0.00125	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—lung cancer	0.000108	0.00124	CcSEcCtD
Methimazole—Somnolence—Methotrexate—lung cancer	0.000107	0.00123	CcSEcCtD
Methimazole—Vomiting—Docetaxel—lung cancer	0.000106	0.00122	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—lung cancer	0.000106	0.00122	CcSEcCtD
Methimazole—Rash—Docetaxel—lung cancer	0.000105	0.00121	CcSEcCtD
Methimazole—Dermatitis—Docetaxel—lung cancer	0.000105	0.00121	CcSEcCtD
Methimazole—Headache—Docetaxel—lung cancer	0.000105	0.0012	CcSEcCtD
Methimazole—Oedema—Doxorubicin—lung cancer	0.000104	0.0012	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—lung cancer	0.000102	0.00117	CcSEcCtD
Methimazole—Nausea—Docetaxel—lung cancer	9.92e-05	0.00114	CcSEcCtD
Methimazole—Urticaria—Methotrexate—lung cancer	9.56e-05	0.0011	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—lung cancer	9.52e-05	0.00109	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.5e-05	0.00109	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—lung cancer	9.36e-05	0.00108	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—lung cancer	9.27e-05	0.00107	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—lung cancer	9.18e-05	0.00105	CcSEcCtD
Methimazole—Pruritus—Methotrexate—lung cancer	8.52e-05	0.000979	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—lung cancer	8.28e-05	0.000952	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—lung cancer	8.24e-05	0.000947	CcSEcCtD
Methimazole—Vomiting—Methotrexate—lung cancer	7.65e-05	0.00088	CcSEcCtD
Methimazole—Rash—Methotrexate—lung cancer	7.59e-05	0.000873	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—lung cancer	7.58e-05	0.000872	CcSEcCtD
Methimazole—Headache—Methotrexate—lung cancer	7.54e-05	0.000867	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—lung cancer	7.37e-05	0.000848	CcSEcCtD
Methimazole—Nausea—Methotrexate—lung cancer	7.15e-05	0.000822	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—lung cancer	6.63e-05	0.000762	CcSEcCtD
Methimazole—Rash—Doxorubicin—lung cancer	6.57e-05	0.000756	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—lung cancer	6.57e-05	0.000755	CcSEcCtD
Methimazole—Headache—Doxorubicin—lung cancer	6.53e-05	0.000751	CcSEcCtD
Methimazole—Nausea—Doxorubicin—lung cancer	6.19e-05	0.000712	CcSEcCtD
Methimazole—CYP2B6—Metabolism—STK11—lung cancer	7.6e-06	8.17e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP1A1—lung cancer	7.59e-06	8.16e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GCLC—lung cancer	7.58e-06	8.15e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP2A6—lung cancer	7.58e-06	8.15e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NCOA3—lung cancer	7.56e-06	8.12e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.55e-06	8.11e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ERCC2—lung cancer	7.53e-06	8.09e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKR1C1—lung cancer	7.46e-06	8.02e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—STK11—lung cancer	7.44e-06	8e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.42e-06	7.98e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCG2—lung cancer	7.41e-06	7.97e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ADCY1—lung cancer	7.41e-06	7.97e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCG2—lung cancer	7.35e-06	7.9e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ADCY1—lung cancer	7.35e-06	7.9e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ENO2—lung cancer	7.27e-06	7.81e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HPGDS—lung cancer	7.27e-06	7.81e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—UGT1A1—lung cancer	7.24e-06	7.79e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.22e-06	7.77e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ENO2—lung cancer	7.21e-06	7.75e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HPGDS—lung cancer	7.21e-06	7.75e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ENO1—lung cancer	7.18e-06	7.72e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPP2R1B—lung cancer	7.16e-06	7.7e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.16e-06	7.69e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.07e-06	7.6e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.07e-06	7.59e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTT1—lung cancer	7.05e-06	7.58e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTP1—lung cancer	7.03e-06	7.56e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RRM1—lung cancer	6.99e-06	7.52e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA3—lung cancer	6.99e-06	7.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTT1—lung cancer	6.99e-06	7.51e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GNG11—lung cancer	6.98e-06	7.51e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GCLC—lung cancer	6.97e-06	7.49e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2A6—lung cancer	6.97e-06	7.49e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.95e-06	7.47e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GCLC—lung cancer	6.91e-06	7.43e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP2A6—lung cancer	6.91e-06	7.43e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTP1—lung cancer	6.89e-06	7.4e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.88e-06	7.4e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CAT—lung cancer	6.84e-06	7.35e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CAT—lung cancer	6.7e-06	7.2e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ABCB1—lung cancer	6.66e-06	7.15e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALDOA—lung cancer	6.65e-06	7.15e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ENO1—lung cancer	6.61e-06	7.1e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—B4GALT5—lung cancer	6.57e-06	7.07e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ENO1—lung cancer	6.55e-06	7.04e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—TYMS—lung cancer	6.54e-06	7.03e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.53e-06	7.01e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ABCB1—lung cancer	6.52e-06	7.01e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—APOA1—lung cancer	6.51e-06	7e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—lung cancer	6.46e-06	6.95e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NCOA3—lung cancer	6.46e-06	6.94e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP2E1—lung cancer	6.44e-06	6.93e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.44e-06	6.92e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—TYMS—lung cancer	6.4e-06	6.88e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA4—lung cancer	6.4e-06	6.87e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NQO1—lung cancer	6.37e-06	6.85e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.34e-06	6.82e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—lung cancer	6.33e-06	6.8e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ADCY1—lung cancer	6.28e-06	6.75e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCG2—lung cancer	6.28e-06	6.75e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.24e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA2—lung cancer	6.23e-06	6.7e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.18e-06	6.64e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HPGDS—lung cancer	6.16e-06	6.62e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ENO2—lung cancer	6.16e-06	6.62e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A1—lung cancer	6.13e-06	6.58e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	6.12e-06	6.58e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ERCC2—lung cancer	6.08e-06	6.53e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.04e-06	6.49e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTA1—lung cancer	6.01e-06	6.46e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A1—lung cancer	6e-06	6.45e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTT1—lung cancer	5.97e-06	6.42e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ERCC2—lung cancer	5.95e-06	6.4e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CG—lung cancer	5.95e-06	6.39e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCC3—lung cancer	5.95e-06	6.39e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2E1—lung cancer	5.93e-06	6.37e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GCLC—lung cancer	5.9e-06	6.35e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2A6—lung cancer	5.9e-06	6.35e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.88e-06	6.32e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP2E1—lung cancer	5.88e-06	6.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NQO1—lung cancer	5.86e-06	6.3e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NQO1—lung cancer	5.81e-06	6.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKR1C1—lung cancer	5.76e-06	6.19e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—STK11—lung cancer	5.74e-06	6.17e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.69e-06	6.11e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—POMC—lung cancer	5.66e-06	6.08e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.64e-06	6.06e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ENO1—lung cancer	5.6e-06	6.02e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—UGT1A1—lung cancer	5.59e-06	6.01e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.58e-06	5.99e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CREBBP—lung cancer	5.51e-06	5.93e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.51e-06	5.92e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.39e-06	5.79e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GNG11—lung cancer	5.39e-06	5.79e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTP1—lung cancer	5.31e-06	5.71e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—STK11—lung cancer	5.28e-06	5.68e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOA1—lung cancer	5.26e-06	5.65e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—STK11—lung cancer	5.24e-06	5.63e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CD—lung cancer	5.23e-06	5.62e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAT—lung cancer	5.17e-06	5.56e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—lung cancer	5.16e-06	5.55e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOA1—lung cancer	5.15e-06	5.53e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.14e-06	5.53e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDOA—lung cancer	5.13e-06	5.52e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—lung cancer	5.03e-06	5.41e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2E1—lung cancer	5.02e-06	5.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NCOA3—lung cancer	4.98e-06	5.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NQO1—lung cancer	4.96e-06	5.34e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—TYMS—lung cancer	4.94e-06	5.31e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.92e-06	5.28e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTP1—lung cancer	4.89e-06	5.25e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—lung cancer	4.88e-06	5.25e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.86e-06	5.22e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ADCY1—lung cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCG2—lung cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTP1—lung cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.82e-06	5.18e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CG—lung cancer	4.8e-06	5.16e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAT—lung cancer	4.76e-06	5.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HPGDS—lung cancer	4.75e-06	5.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ENO2—lung cancer	4.75e-06	5.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.72e-06	5.08e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAT—lung cancer	4.72e-06	5.07e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CG—lung cancer	4.7e-06	5.05e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.69e-06	5.04e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A1—lung cancer	4.63e-06	4.98e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—lung cancer	4.63e-06	4.97e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTT1—lung cancer	4.61e-06	4.96e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ERCC2—lung cancer	4.59e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—lung cancer	4.59e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—POMC—lung cancer	4.57e-06	4.91e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2A6—lung cancer	4.56e-06	4.9e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CB—lung cancer	4.56e-06	4.9e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GCLC—lung cancer	4.56e-06	4.9e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TYMS—lung cancer	4.54e-06	4.88e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—lung cancer	4.52e-06	4.85e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TYMS—lung cancer	4.5e-06	4.84e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—lung cancer	4.49e-06	4.83e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—STK11—lung cancer	4.47e-06	4.81e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—POMC—lung cancer	4.47e-06	4.81e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—lung cancer	4.45e-06	4.79e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CREBBP—lung cancer	4.45e-06	4.78e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CREBBP—lung cancer	4.36e-06	4.68e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ENO1—lung cancer	4.32e-06	4.64e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A1—lung cancer	4.26e-06	4.58e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ERCC2—lung cancer	4.22e-06	4.54e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A1—lung cancer	4.22e-06	4.54e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CD—lung cancer	4.22e-06	4.53e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.2e-06	4.51e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ERCC2—lung cancer	4.19e-06	4.5e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—lung cancer	4.16e-06	4.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTP1—lung cancer	4.14e-06	4.45e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CD—lung cancer	4.13e-06	4.44e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—lung cancer	4.08e-06	4.38e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAT—lung cancer	4.03e-06	4.33e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.01e-06	4.31e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOA1—lung cancer	3.97e-06	4.27e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—lung cancer	3.94e-06	4.23e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—lung cancer	3.92e-06	4.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2E1—lung cancer	3.87e-06	4.16e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TYMS—lung cancer	3.85e-06	4.14e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NQO1—lung cancer	3.83e-06	4.12e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—lung cancer	3.81e-06	4.09e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.8e-06	4.09e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—EP300—lung cancer	3.76e-06	4.04e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CB—lung cancer	3.68e-06	3.95e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOA1—lung cancer	3.65e-06	3.93e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—lung cancer	3.64e-06	3.92e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CG—lung cancer	3.63e-06	3.9e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOA1—lung cancer	3.62e-06	3.89e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1A1—lung cancer	3.61e-06	3.88e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CB—lung cancer	3.6e-06	3.87e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ERCC2—lung cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—lung cancer	3.57e-06	3.84e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.47e-06	3.73e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—STK11—lung cancer	3.45e-06	3.71e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—POMC—lung cancer	3.45e-06	3.71e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CREBBP—lung cancer	3.36e-06	3.61e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CG—lung cancer	3.34e-06	3.58e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CG—lung cancer	3.31e-06	3.55e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTP1—lung cancer	3.2e-06	3.43e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CD—lung cancer	3.19e-06	3.43e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—lung cancer	3.18e-06	3.41e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—POMC—lung cancer	3.17e-06	3.41e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—POMC—lung cancer	3.15e-06	3.38e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—lung cancer	3.15e-06	3.38e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—lung cancer	3.11e-06	3.34e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAT—lung cancer	3.11e-06	3.34e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOA1—lung cancer	3.09e-06	3.33e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CREBBP—lung cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CREBBP—lung cancer	3.07e-06	3.29e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—EP300—lung cancer	3.03e-06	3.26e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—lung cancer	3.02e-06	3.25e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TYMS—lung cancer	2.97e-06	3.19e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—EP300—lung cancer	2.97e-06	3.19e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.96e-06	3.19e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—lung cancer	2.94e-06	3.16e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CD—lung cancer	2.93e-06	3.15e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CD—lung cancer	2.91e-06	3.12e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—lung cancer	2.89e-06	3.11e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—lung cancer	2.87e-06	3.08e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CG—lung cancer	2.83e-06	3.04e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A1—lung cancer	2.78e-06	2.99e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CB—lung cancer	2.78e-06	2.99e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—lung cancer	2.78e-06	2.99e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ERCC2—lung cancer	2.76e-06	2.97e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—lung cancer	2.75e-06	2.96e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—POMC—lung cancer	2.69e-06	2.89e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CREBBP—lung cancer	2.62e-06	2.82e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CB—lung cancer	2.56e-06	2.75e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CB—lung cancer	2.53e-06	2.72e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—lung cancer	2.53e-06	2.72e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—lung cancer	2.51e-06	2.7e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CD—lung cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—lung cancer	2.45e-06	2.64e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—lung cancer	2.4e-06	2.58e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOA1—lung cancer	2.39e-06	2.57e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—EP300—lung cancer	2.29e-06	2.46e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—lung cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—lung cancer	2.24e-06	2.41e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—lung cancer	2.21e-06	2.37e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—lung cancer	2.2e-06	2.36e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—lung cancer	2.19e-06	2.35e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CG—lung cancer	2.18e-06	2.34e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CB—lung cancer	2.16e-06	2.33e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—lung cancer	2.15e-06	2.31e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—EP300—lung cancer	2.11e-06	2.26e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—EP300—lung cancer	2.09e-06	2.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—POMC—lung cancer	2.08e-06	2.23e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CREBBP—lung cancer	2.02e-06	2.17e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CD—lung cancer	1.92e-06	2.06e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—lung cancer	1.89e-06	2.03e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—lung cancer	1.87e-06	2.01e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—lung cancer	1.83e-06	1.97e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—lung cancer	1.79e-06	1.93e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—EP300—lung cancer	1.78e-06	1.92e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—lung cancer	1.69e-06	1.82e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CB—lung cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—lung cancer	1.66e-06	1.78e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—lung cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—lung cancer	1.54e-06	1.66e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—lung cancer	1.44e-06	1.55e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—lung cancer	1.38e-06	1.49e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—EP300—lung cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—lung cancer	1.32e-06	1.42e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—lung cancer	1.27e-06	1.37e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—lung cancer	1.26e-06	1.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—lung cancer	1.08e-06	1.16e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—lung cancer	1.02e-06	1.09e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—lung cancer	8.32e-07	8.94e-06	CbGpPWpGaD
